137 related articles for article (PubMed ID: 25526329)
41. The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases.
Plaza JA; Kacerovska D; Stockman DL; Buonaccorsi JN; Baillargeon P; Suster S; Kazakov DV
Am J Dermatopathol; 2011 Oct; 33(7):649-55; quiz 656-8. PubMed ID: 21937906
[TBL] [Abstract][Full Text] [Related]
42. Routine bone marrow biopsy in the initial evaluation of primary cutaneous B-cell lymphoma does not appear justified.
Quereux G; Frot AS; Brocard A; Leux C; Renaut JJ; Dreno B
Eur J Dermatol; 2009; 19(3):216-20. PubMed ID: 19251565
[TBL] [Abstract][Full Text] [Related]
43. Primary cutaneous B-cell lymphoma treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems.
Smith BD; Glusac EJ; McNiff JM; Smith GL; Heald PW; Cooper DL; Wilson LD
J Clin Oncol; 2004 Feb; 22(4):634-9. PubMed ID: 14966086
[TBL] [Abstract][Full Text] [Related]
44. Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas--an applicational observation.
Gellrich S; Muche JM; Wilks A; Jasch KC; Voit C; Fischer T; Audring H; Sterry W
Br J Dermatol; 2005 Jul; 153(1):167-73. PubMed ID: 16029344
[TBL] [Abstract][Full Text] [Related]
45. Spindle B-cell lymphoma: a rare variant of follicle center lymphoma.
Elwan NM; Abdel Salam S; Radwan NS
J Cutan Pathol; 2016 May; 43(5):451-5. PubMed ID: 26955785
[TBL] [Abstract][Full Text] [Related]
46. [Cutaneous follicular center B-cell lymphoma treated with intralesional rituximab].
Gamo R; Calzado L; Pinedo F; López-Estebaranz JL
Actas Dermosifiliogr; 2008 May; 99(4):291-6. PubMed ID: 18394405
[TBL] [Abstract][Full Text] [Related]
47. Clonal evolution in a primary cutaneous follicle center B cell lymphoma revealed by single cell analysis in sequential biopsies.
Golembowski S; Gellrich S; von Zimmermann M; Rutz S; Lippert S; Audring H; Lorenz P; Sterry W; Jahn S
Immunobiology; 2000 Apr; 201(5):631-44. PubMed ID: 10834319
[TBL] [Abstract][Full Text] [Related]
48. Primary cutaneous B-cell lymphomas: part II. Therapy and future directions.
Suárez AL; Querfeld C; Horwitz S; Pulitzer M; Moskowitz A; Myskowski PL
J Am Acad Dermatol; 2013 Sep; 69(3):343.e1-11; quiz 355-6. PubMed ID: 23957985
[TBL] [Abstract][Full Text] [Related]
49. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
[TBL] [Abstract][Full Text] [Related]
50. Recurrent localized primary cutaneous marginal-zone B cell lymphoma.
Marmon S; Chu J; Patel R; Meehan S; Pomeranz MK
Dermatol Online J; 2011 Oct; 17(10):27. PubMed ID: 22031653
[TBL] [Abstract][Full Text] [Related]
51. Utility of microdissection and polymerase chain reaction for the detection of immunoglobulin gene rearrangement and translocation in primary intraocular lymphoma.
Shen DF; Zhuang Z; LeHoang P; Böni R; Zheng S; Nussenblatt RB; Chan CC
Ophthalmology; 1998 Sep; 105(9):1664-9. PubMed ID: 9754175
[TBL] [Abstract][Full Text] [Related]
52. Recent advances in primary cutaneous B-cell lymphomas.
Vermeer MH; Willemze R
Curr Opin Oncol; 2014 Mar; 26(2):230-6. PubMed ID: 24463347
[TBL] [Abstract][Full Text] [Related]
53. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Dutch Cutaneous Lymphoma Working Group.
Vermeer MH; Geelen FA; van Haselen CW; van Voorst Vader PC; Geerts ML; van Vloten WA; Willemze R
Arch Dermatol; 1996 Nov; 132(11):1304-8. PubMed ID: 8915307
[TBL] [Abstract][Full Text] [Related]
54. Lymphoproliferative lesions of the skin.
Cerroni L
J Clin Pathol; 2006 Aug; 59(8):813-26. PubMed ID: 16873563
[TBL] [Abstract][Full Text] [Related]
55. Cutaneous B-cell lymphoma: pathological spectrum and clinical outcome in 51 consecutive patients.
Sah A; Barrans SL; Parapia LA; Jack AS; Owen RG
Am J Hematol; 2004 Apr; 75(4):195-9. PubMed ID: 15054808
[TBL] [Abstract][Full Text] [Related]
56. Cutaneous follicle center lymphomas with plasmacytic differentiation.
Skala SL; Harms PW; Fullen DR; Brown NA; Tejasvi T; Wilcox RA; Boyer DF; Hristov AC
J Cutan Pathol; 2021 May; 48(5):632-636. PubMed ID: 33184902
[TBL] [Abstract][Full Text] [Related]
57. Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma.
Colovic N; Jurisic V; Terzic T; Atkinson HD; Colovic M
Arch Dermatol Res; 2009 Oct; 301(9):689-92. PubMed ID: 19495780
[TBL] [Abstract][Full Text] [Related]
58. Primary cutaneous B cell lymphoma presenting as recurrent eyelid swelling.
Pandya VB; Conway RM; Taylor SF
Clin Exp Ophthalmol; 2008 Oct; 36(7):672-4. PubMed ID: 18983553
[TBL] [Abstract][Full Text] [Related]
59. Primary cutaneous follicle center lymphoma associated with alopecia areata.
Richmond HM; Lozano A; Jones D; Duvic M
Clin Lymphoma Myeloma; 2008 Apr; 8(2):121-4. PubMed ID: 18501107
[TBL] [Abstract][Full Text] [Related]
60. T-Cell-Rich Recurrence of Primary Cutaneous Follicle Center Lymphoma After Systemic Rituximab: A Diagnostic Pitfall.
Santonja C; Prieto-Torres L; Pérez-Sáenz MLÁ; Requena L; Rodríguez-Pinilla SM
Am J Dermatopathol; 2020 Mar; 42(3):e36-e40. PubMed ID: 31592859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
